A 61-year-old with recurrent CDI after fidaxomicin asks about bezlotoxumab. Which statement is true?...

Question

A 61-year-old with recurrent CDI after fidaxomicin asks about bezlotoxumab. Which statement is true?

Accepted Answer

Bezlotoxumab can be given with standard-of-care antibiotics to reduce recurrence in high-risk patients

Answer

Bezlotoxumab replaces antibiotics

Answer

It treats acute CDI as monotherapy

Answer

Contraindicated in heart failure always

Answer

Not indicated after one recurrence

us-abim MCQ (SBA): Recurrent CDI Prevention